blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1485072

EP1485072 - HORMONE-CONTAINING TRANSDERMAL THERAPEUTIC SYSTEM WITH AN ACTIVE SUBSTANCE RESERVOIR BASED ON VINYLACETATE-VINYLPYRROLIDONE COPOLYMER WITH IMPROVED COHESION. [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  05.03.2010
Database last updated on 03.10.2024
Most recent event   Tooltip19.10.2012Lapse of the patent in a contracting state
New state(s): TR		published on 21.11.2012  [2012/47]
Applicant(s)For all designated states
LTS LOHMANN Therapie-Systeme AG
Lohmannstrasse 2
56626 Andernach / DE
[2009/18]
Former [2004/51]For all designated states
LTS Lohmann Therapie-Systeme AG
Lohmannstrasse 2
56626 Andernach / DE
Inventor(s)01 / MECONI, Reinhold
Alemannenstrasse 42
56567 Neuwied / DE
02 / KLEIN, Robert-Peter
Wikingerstrasse 3
56567 Neuwied / DE
03 / SEIBERTZ, Frank
Arienhellerstr. 64
56598 Rheinbrohl / DE
04 / BECKER, Franz-Josef
Ringmauer 14
56567 Neuwied / DE
05 / GÖTTE, Ursula
Im Horsberg 7
53572 Unkel / DE
 [2004/51]
Representative(s)Flaccus, Rolf-Dieter
Flaccus Müller-Wolff
Patentanwälte
Bussardweg 10
50389 Wesseling / DE
[N/P]
Former [2008/40]Flaccus, Rolf-Dieter
Patentanwalt Bussardweg 10
50389 Wesseling / DE
Former [2004/51]Flaccus, Rolf-Dieter
Patentanwalt Bussardweg 10
50389 Wesseling / DE
Application number, filing date03744351.212.03.2003
[2004/51]
WO2003EP02521
Priority number, dateDE200211183216.03.2002         Original published format: DE 10211832
[2004/51]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO03077890
Date:25.09.2003
Language:DE
[2003/39]
Type: A1 Application with search report 
No.:EP1485072
Date:15.12.2004
Language:DE
The application published by WIPO in one of the EPO official languages on 25.09.2003 takes the place of the publication of the European patent application.
[2004/51]
Type: B1 Patent specification 
No.:EP1485072
Date:29.04.2009
Language:DE
[2009/18]
Search report(s)International search report - published on:EP25.09.2003
ClassificationIPC:A61K9/70, A61K31/565, A61K47/32
[2004/51]
CPC:
A61K9/7053 (EP,US); A61K31/565 (EP,US); A61K47/32 (EP,US);
A61P15/12 (EP); A61P15/18 (EP); A61P19/10 (EP);
A61P5/30 (EP); A61P5/34 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2004/51]
TitleGerman:HORMONHALTIGES TRANSDERMALES THERAPEUTISCHES SYSTEM MIT EINEM WIRKSTOFFRESERVOIR AUF DER BASIS VON VINYLACETAT-VINYLPYRROLIDON-COPOLYMER MIT VERBESSERTER KOHÄSION.[2008/52]
English:HORMONE-CONTAINING TRANSDERMAL THERAPEUTIC SYSTEM WITH AN ACTIVE SUBSTANCE RESERVOIR BASED ON VINYLACETATE-VINYLPYRROLIDONE COPOLYMER WITH IMPROVED COHESION.[2004/51]
French:SYSTEME THERAPEUTIQUE TRANSDERMIQUE CONTENANT DES HORMONES, COMPORTANT UN RESERVOIR D'AGENTS ACTIFS A BASE DE COPOLYMERE DE VINYLACETATE-VINYLPYRROLIDONE PRESENTANT UNE MEILLEURE COHESION[2004/51]
Former [2004/51]HORMONHALTIGES TRANSDERMALES THERAPEUTISCHES SYSTEM MIT EINEM WIRKSTOFFRESERVOIR AUF DER BASIS VON VINYLACETAT-VINYLPYRROLIDON-COPOLYMER MIT VERBESSERTER KOH SION.
Entry into regional phase09.08.2004National basic fee paid 
09.08.2004Designation fee(s) paid 
09.08.2004Examination fee paid 
Examination procedure08.08.2003Request for preliminary examination filed
International Preliminary Examining Authority: EP
09.08.2004Examination requested  [2004/51]
16.07.2007Despatch of a communication from the examining division (Time limit: M04)
13.11.2007Reply to a communication from the examining division
12.12.2008Communication of intention to grant the patent
10.03.2009Fee for grant paid
10.03.2009Fee for publishing/printing paid
Opposition(s)01.02.2010No opposition filed within time limit [2010/14]
Fees paidRenewal fee
08.03.2005Renewal fee patent year 03
15.03.2006Renewal fee patent year 04
14.03.2007Renewal fee patent year 05
13.03.2008Renewal fee patent year 06
13.03.2009Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY29.04.2009
CZ29.04.2009
DK29.04.2009
EE29.04.2009
FI29.04.2009
IE29.04.2009
NL29.04.2009
RO29.04.2009
SI29.04.2009
SK29.04.2009
TR29.04.2009
BG29.07.2009
SE29.07.2009
GR30.07.2009
PT29.08.2009
HU30.10.2009
[2012/47]
Former [2012/42]CY29.04.2009
CZ29.04.2009
DK29.04.2009
EE29.04.2009
FI29.04.2009
IE29.04.2009
NL29.04.2009
RO29.04.2009
SI29.04.2009
SK29.04.2009
BG29.07.2009
SE29.07.2009
GR30.07.2009
PT29.08.2009
HU30.10.2009
Former [2012/37]CY29.04.2009
CZ29.04.2009
DK29.04.2009
EE29.04.2009
FI29.04.2009
IE29.04.2009
NL29.04.2009
RO29.04.2009
SI29.04.2009
SK29.04.2009
BG29.07.2009
SE29.07.2009
GR30.07.2009
PT29.08.2009
Former [2010/48]CZ29.04.2009
DK29.04.2009
EE29.04.2009
FI29.04.2009
IE29.04.2009
NL29.04.2009
RO29.04.2009
SI29.04.2009
SK29.04.2009
BG29.07.2009
SE29.07.2009
GR30.07.2009
PT29.08.2009
Former [2010/18]CZ29.04.2009
DK29.04.2009
EE29.04.2009
FI29.04.2009
IE29.04.2009
NL29.04.2009
RO29.04.2009
SI29.04.2009
SK29.04.2009
BG29.07.2009
SE29.07.2009
PT29.08.2009
Former [2010/10]CZ29.04.2009
DK29.04.2009
EE29.04.2009
FI29.04.2009
IE29.04.2009
NL29.04.2009
RO29.04.2009
SI29.04.2009
SK29.04.2009
SE29.07.2009
PT29.08.2009
Former [2010/09]CZ29.04.2009
DK29.04.2009
EE29.04.2009
FI29.04.2009
IE29.04.2009
NL29.04.2009
RO29.04.2009
SI29.04.2009
SE29.07.2009
PT29.08.2009
Former [2010/08]DK29.04.2009
EE29.04.2009
FI29.04.2009
IE29.04.2009
NL29.04.2009
SI29.04.2009
SE29.07.2009
PT29.08.2009
Former [2010/07]FI29.04.2009
IE29.04.2009
NL29.04.2009
SI29.04.2009
SE29.07.2009
PT29.08.2009
Former [2009/51]FI29.04.2009
NL29.04.2009
SI29.04.2009
SE29.07.2009
PT29.08.2009
Former [2009/50]FI29.04.2009
NL29.04.2009
PT29.08.2009
Former [2009/49]FI29.04.2009
PT29.08.2009
Cited inInternational search[X]DE19613698  (SCHERING AG [DE]) [X] 1-23 * column 6, line 24 - line 34 * * column 9; example 5 *;
 [X]WO9802147  (SCHERING AG [DE], et al) [X] 1-23 * page 10; example 6 *;
 [A]US5919478  (LANDRAU FELIX A [US], et al) [A] 1-23 * the whole document *;
 [X]US6007835  (BON-LAPILLONNE CHANTAL [FR], et al) [X] 1-23 * column 6, line 34 - line 43 * * column 7, line 8 - line 63 * * column 8, lines 1-32 * * example 1 * * claim 1 *;
 [A]DE10012908  (LOHMANN THERAPIE SYST LTS [DE]) [A] 1-23 * the whole document *;
 [DX]WO0189487  (LTS LOHMANN THERAPIE SYSTEM AG [DE], et al) [DX] 1-23 * page 8; example 1 * * claims 1-17 *;
 [PX]WO02102390  (NOVEN PHARMA [US], et al) [PX] 1-23* page 26 - page 27; examples 1,2 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.